Data Availability
Data used for this study will be made available upon reasonable request to the corresponding author.
Change history
24 April 2023
A Correction to this paper has been published: https://doi.org/10.1007/s00415-023-11721-2
Abbreviations
- IS:
-
Ischemic stroke
- MA:
-
Migraine aura
- AHA/ASA:
-
American Heart Association/American Stroke Association
- ICHD:
-
International Classification of Headache Disorders
- PFO:
-
Patent foramen ovale
- PCA:
-
Posterior cerebral artery
- MCA:
-
Middle cerebral artery
- CSD:
-
Cortical spreading depolarization
References
Fisher CM (1968) Migraine accompaniments versus arteriosclerotic ischemia. Trans Am Neurol Assoc 93:211–213
Waters MJ, Cheong E, Jannes J, Kleinig T (2018) Ischaemic stroke may symptomatically manifest as migraine aura. J Clin Neurosci 55:62–64
Olesen J, Friberg L, Olsen TS et al (1993) Ischaemia-induced (symptomatic) migraine attacks may be more frequent than migraine-induced ischaemic insults. Brain 116(Pt 1):187–202
Cohen SN, Muthukumaran A, Gasser H, El-Saden S (2002) Symptom spread to contiguous body parts as a presentation of cerebral ischemia. Cerebrovasc Dis 14(2):84–89
Whiteley WN, MacRaild A, Wang Y et al (2022) Diagnosis and magnetic resonance imaging in patients with transient and minor neurological symptoms: a prospective cohort study. Stroke 9:101161STROKEAHA122039082
Scutelnic A, Kreis LA, Beyeler M et al (2022) Migraine aura-like symptoms at onset of stroke and stroke-like symptoms in migraine with aura. Front Neurol 13:1004058
Coutts SB, Moreau F, Asdaghi N et al (2019) Diagnosis of Uncertain-Origin Benign Transient Neurological Symptoms (DOUBT) Study Group. Rate and prognosis of brain ischemia in patients with lower-risk transient or persistent minor neurologic events. JAMA Neurol 76(12):1439–1445
Easton JD, Saver JL, Albers GW et al (2013) American Heart Association Stroke Council, Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular and Stroke Nursing; Council on Epidemiology and Prevention; Council on Peripheral Vascular Disease; Council on Nutrition, Physical Activity and Metabolism. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44(7):2064–2089
Headache Classification Committee of the International Headache Society (IHS) (2018) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38(1):1–211
Guedes R, de Oliveira J, Amâncio-Dos-Santos A, García-Cairasco N (2009) Sexual differentiation of cortical spreading depression propagation after acute and kindled audiogenic seizures in the Wistar audiogenic rat (WAR). Epilepsy Res 83:207–214
Guedes RCA, Abadie-Guedes R (2019) Brain aging and electrophysiological signaling: revisiting the spreading depression model. Front Aging Neurosci 7(11):136
Dohmen C, Sakowitz OW, Fabricius M et al (2008) Co-Operative Study of Brain Injury Depolarisations (COSBID). Spreading depolarizations occur in human ischemic stroke with high incidence. Ann Neurol 63(6):720–728
Cohen C, Gaillot K, Ifergan H et al (2022) Quantitative analysis of thrombus migration before mechanical thrombectomy: Determinants and relationship with procedural and clinical outcomes. J Neurorad 49(5):385–391
Collins CE, Airey DC, Young NA, Leitch DB, Kaas JH (2010) Neuron densities vary across and within cortical areas in primates. Proc Natl Acad Sci U S A 107(36):15927–15932
Lauritzen M, Dreier JP, Fabricius M, Hartings JA, Graf R, Strong AJ (2011) Clinical relevance of cortical spreading depression in neurological disorders: migraine, malignant stroke, subarachnoid and intracranial hemorrhage, and traumatic brain injury. J Cereb Blood Flow Metab 31(1):17–35
Hauge AW, Asghar MS, Schytz HW, Christensen K, Olesen J (2009) Effects of tonabersat on migraine with aura: a randomised, double-blind, placebo-controlled crossover study. Lancet Neurol 8(8):718–723
Thomsen AV, Sørensen MT, Ashina M, Hougaard A (2021) Symptomatic migraine: a systematic review to establish a clinically important diagnostic entity. Headache 61(8):1180–1193
Funding
This study received research support from the Swiss Heart Foundation (FF21070).
Author information
Authors and Affiliations
Contributions
Study concept: LJ, AS, CJS, SJ; data acquisition: LJ, AS, MB; data analysis: LJ, AS, MB; drafting of the manuscript: LJ, AS, CJS, SJ; writing the subsequent drafts: all authors; critical revision of the article for intellectual content: all authors.
Corresponding author
Ethics declarations
Conflicts of interest
LJ, MB, MBr, MBe, TRM, SN, DB: none. AS and SJ report research support from the Swiss Heart Foundation. DS reports grants from Bangerter Rhyner Foundation during the conduct of the study; personal fees from Bayer, Alexion, and VarmX outside the submitted work. UF: consulting for Medtronic, Stryker, CSL Behring. Advisory boards for Portola/Alexion (money paid to institution). MA reports personal fees from AstraZeneca, Bayer, Bristol Myers Squibb, Covidien, Daiichy Sankyo, Medtronic, Novartis, Pfizer, and Amgen. HPM: Grants from Abbott for the PC and PRIMA trials and from Cerenovus for the ARISE studies. Personal and speaker fees from Cerenovus, Bayer, Servier, Medtronic and Stryker. CJS: consulting, advisory boards, speaker, travel support for/from Novartis, Eli Lilly, TEVA Pharmaceuticals, Allergan, Almirall, Amgen, Lundbeck, MindMed, Grünenthal. Part-time-employee at Zynnon.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Scutelnic, A., Justus, L., Branca, M. et al. Factors associated with migraine aura-like symptoms in acute ischemic stroke. J Neurol 270, 3637–3641 (2023). https://doi.org/10.1007/s00415-023-11694-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-023-11694-2